How Much Does Testosterone Enanthate Cost in California in 2026?

California Retail Pricing Breakdown

The average cash-pay price for testosterone enanthate across California retail pharmacies is $70 per month in 2026, based on a standard once-weekly intramuscular injection regimen. That figure applies to the branded multi-dose vial (typically 200 mg/mL, 5 mL). Prices vary by pharmacy chain, city, and whether you use a discount card.

Brand vs. Generic Pricing

Generic testosterone enanthate accounts for the majority of prescriptions filled in the state. A 5 mL vial of generic testosterone enanthate (1,000 mg total) costs between $40 and $90 at most California chain pharmacies, depending on location. The branded product can run up to $120 per month at list price. The FDA-approved labeling for testosterone enanthate injection specifies intramuscular use for conditions associated with testosterone deficiency in adult males [1].

Regional Price Variation

Pharmacy pricing in California is not uniform. Los Angeles and San Francisco metro areas tend to sit at or slightly above the $70 state average, while pharmacies in the Central Valley and rural Northern California sometimes price 10 to 15 percent lower. Costco and independent pharmacies often undercut CVS and Walgreens by $10 to $20 on a cash-pay basis.

Why Prices Differ So Much

Testosterone enanthate is a generic injectable with multiple manufacturers. Competition keeps the wholesale acquisition cost low. But retail markups, dispensing fees, and local market dynamics create a spread. Checking two or three pharmacies before filling is worth the five minutes it takes.

Medi-Cal Coverage for Testosterone Enanthate

Medi-Cal, California's Medicaid program, covers testosterone enanthate for the treatment of male hypogonadism. Coverage requires prior authorization (PA). Your prescriber must document a confirmed diagnosis, typically supported by at least two morning serum testosterone levels below 300 ng/dL, along with signs or symptoms of androgen deficiency [2].

What the Prior Authorization Requires

The PA process for Medi-Cal generally requires the prescriber to submit lab results (two separate morning total testosterone draws), a documented clinical indication (fatigue, sexual dysfunction, decreased lean mass), and confirmation that the patient does not have contraindications such as untreated polycythemia, breast cancer, or unevaluated prostate nodules. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic androgen deficiency confirmed by consistently low serum testosterone concentrations [2].

Approval Timelines

Most Medi-Cal PA decisions come back within five to ten business days. Denials can be appealed. If your prescriber submits complete documentation on the first attempt, approval rates are high for straightforward hypogonadism cases.

Managed Medi-Cal Plans

California operates Medi-Cal through managed care plans in most counties. Plans like L.A. Care, Health Net, Molina, and CalOptima may have slightly different formulary placements and PA criteria, but testosterone enanthate appears on the preferred drug lists of most Medi-Cal managed care organizations when prescribed for FDA-approved indications.

Commercial Insurance Coverage in California

Most large commercial insurers in California place testosterone enanthate on their formularies, usually at Tier 2 (preferred generic) or Tier 3. Copays typically range from $10 to $45 per month depending on the plan.

Plans That Commonly Cover It

Blue Shield of California, Anthem Blue Cross, Kaiser Permanente, Health Net, and UnitedHealthcare all include generic testosterone enanthate on their standard formularies for California members. Kaiser Permanente members fill at Kaiser pharmacies, where the copay is often $15 to $20 for a 30-day supply under most HMO plans.

Prior Authorization and Step Therapy

Some commercial plans require PA similar to Medi-Cal. A few mandate step therapy, meaning you may need to document that topical testosterone (such as AndroGel or generic testosterone gel) was tried and either failed or was not tolerated before an injectable formulation is approved. The T-Trials, a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine, demonstrated that testosterone treatment in men 65 and older with low testosterone improved sexual function, physical function, and bone density over 12 months (N=790) [3]. These findings support the clinical rationale insurers use when authorizing treatment.

Out-of-Pocket Maximums

If you have a high-deductible health plan (HDHP), you may pay full cash price until your deductible is met. In that scenario, using a GoodRx coupon or manufacturer savings card alongside your insurance claim can sometimes reduce your net cost. Ask your pharmacist to run both the insurance and the discount card to see which price is lower.

Compounded Testosterone Enanthate in California

Compounded testosterone enanthate is legal in California when dispensed by a licensed 503A compounding pharmacy operating under California State Board of Pharmacy oversight. The average price is roughly $80 per month.

503A vs. 503B Pharmacies

A 503A pharmacy compounds individual prescriptions based on a specific patient's order from a licensed prescriber. A 503B outsourcing facility compounds in bulk without individual prescriptions and is registered with the FDA. Both operate in California. The 503A route is more common for patients seeking customized testosterone enanthate concentrations or preservative-free formulations.

When Compounding Makes Sense

Compounding is most useful when a patient needs a non-standard concentration, has an allergy to a component of the commercially available product (such as the sesame oil or chlorobutanol preservative), or prefers a different carrier oil. For most patients, the commercially available generic is cheaper and more straightforward.

Verifying a California Compounder

Before filling at a compounding pharmacy, verify its license through the California State Board of Pharmacy's online license lookup. Confirm the pharmacy holds a current sterile compounding license if you are receiving an injectable product. The board conducts inspections and publishes enforcement actions publicly.

Telehealth Access to Testosterone Enanthate in California

California permits prescribing testosterone enanthate via telehealth. State law allows controlled substance prescribing through audio-video telemedicine visits when the prescriber establishes a legitimate patient-provider relationship [4].

How a Telehealth Visit Works

You schedule a video consultation with a licensed California prescriber (physician, nurse practitioner, or physician assistant). The clinician reviews your symptoms, orders lab work (usually through a local Quest or Labcorp draw site), and evaluates results. If you meet diagnostic criteria for hypogonadism, the prescription is sent electronically to your pharmacy of choice.

DEA and State Requirements

Testosterone enanthate is a Schedule III controlled substance under federal law. The DEA permits telemedicine prescribing when the encounter meets specific conditions, including a real-time audio-video interaction. California does not impose additional restrictions beyond the federal framework for testosterone prescribing via telemedicine, though the prescriber must hold a valid California medical license and DEA registration.

Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has stated: "Testosterone therapy, when properly indicated and monitored, is one of the most effective treatments we have for men with symptomatic hypogonadism" [5]. That perspective reflects the growing acceptance of telehealth-initiated testosterone treatment protocols.

Discount Programs and Savings Strategies

Several pathways exist to reduce your out-of-pocket cost for testosterone enanthate in California beyond insurance.

Manufacturer Copay Cards

Some generic manufacturers offer savings cards that reduce cash-pay prices by $20 to $40 per fill. Eligibility usually excludes patients with government insurance (Medi-Cal, Medicare, Tricare). These cards work at most retail pharmacies and can be presented alongside or instead of insurance.

GoodRx and Similar Platforms

GoodRx, RxSaver, and SingleCare all list testosterone enanthate coupons for California pharmacies. Prices through these platforms frequently drop to $35 to $55 for a 5 mL vial, undercutting both the average cash price and many insurance copays. The coupon is free to use and does not require insurance.

Patient Assistance Programs

Patients who are uninsured and meet income thresholds may qualify for patient assistance from the manufacturer or through programs like NeedyMeds and RxAssist. These programs can reduce cost to $0 for qualifying individuals, though application processing takes two to four weeks.

Splitting Vials and Supply Efficiency

A standard 5 mL vial of testosterone enanthate 200 mg/mL contains 1,000 mg total. At a common dose of 100 mg per week, one vial lasts approximately 10 weeks. Purchasing one vial every 10 weeks instead of monthly refills reduces per-month cost. Discuss multi-dose vial use with your prescriber and pharmacist to optimize supply.

Monitoring Costs to Factor In

The price of testosterone itself is only part of the total treatment cost. Ongoing monitoring labs add to the annual expense.

Required Lab Work

The Endocrine Society recommends checking hematocrit, serum testosterone, and PSA (in men over 40) at baseline, 3 to 6 months after starting therapy, then annually [2]. A basic testosterone and CBC panel through Quest Diagnostics or Labcorp costs $50 to $150 out of pocket per draw. Most insurance plans cover monitoring labs when linked to a hypogonadism diagnosis.

Supplies

Syringes, needles, and alcohol swabs for self-injection run about $5 to $10 per month when purchased in bulk. Some pharmacies include supplies with the prescription fill at no extra charge.

Total Annual Cost Estimate

For an uninsured California patient paying cash at retail prices: testosterone enanthate ($70/month x 12 = $840), labs ($100 x 2 draws = $200), and supplies ($7/month x 12 = $84). That puts the annual all-in cost at roughly $1,124 before any discount cards or coupons. With GoodRx pricing and efficient vial use, the total can drop below $700 per year.

Clinical Context for Testosterone Enanthate

Testosterone enanthate is one of the most widely prescribed formulations of exogenous testosterone worldwide. Its half-life of approximately 4.5 days supports once-weekly or biweekly dosing for stable serum levels [1].

Efficacy Data

The landmark T-Trials enrolled 790 men aged 65 and older with serum testosterone below 275 ng/dL and symptoms of deficiency. Over 12 months, testosterone gel treatment (which achieves comparable steady-state levels to enanthate injections) improved sexual activity scores by 0.58 points on a 12-point scale versus placebo, increased 6-minute walk distance, and raised volumetric bone mineral density at the spine by 7.5% compared to placebo [3]. While the T-Trials used a gel formulation, the Endocrine Society guideline treats injectable testosterone enanthate as pharmacologically equivalent when dosed to achieve the same target serum range of 450 to 600 ng/dL [2].

Safety Considerations

Polycythemia (hematocrit above 54%) is the most common adverse effect requiring dose adjustment. In the T-Trials, the testosterone group had a slightly higher incidence of coronary artery plaque volume increase compared to placebo, a finding that prompted the FDA to add cardiovascular risk language to testosterone product labeling in 2015 [6]. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone replacement in men aged 45 to 80 with hypogonadism and cardiovascular risk factors did not significantly increase the incidence of major adverse cardiovascular events over a mean follow-up of 33 months (7.0% testosterone vs. 7.3% placebo; hazard ratio 0.96, 95% CI 0.78 to 1.17) [7].

The American Urological Association's 2018 guideline states: "Clinicians should inform patients of the absence of evidence linking testosterone therapy to the development of prostate cancer" [8]. That guidance remains current and supports informed consent discussions about long-term injectable testosterone use.

Patients starting testosterone enanthate in California should have baseline hematocrit, lipid panel, and PSA (if over 40) checked before the first injection, with follow-up labs at 3 months and then annually per Endocrine Society recommendations [2].